98
Participants
Start Date
January 4, 2021
Primary Completion Date
January 10, 2022
Study Completion Date
June 29, 2022
Placebo
Given IV
LY3462817
Given IV
Latin Clinical Trial Center, San Juan
Revita Clinic, Budapest
Budai Irgalmasrendi Korhaz, Budapest
Clinexpert Egeszsegugyi Szolgaltato es Kereskedelmi Kft., Budapest
CRU Hungary Kft., Miskolc
Vital Medical Center, Veszprém
Altoona Center For Clinical Research, Duncansville
Centro Medico del Angel, Mexicali
Investigacion y Biomedicina de Chihuahua, Chihuahua City
Centro de Estudios de Investigacion Basica y Clinica, S.C., Guadalajara
Physician Research Collaboration, LLC, Lincoln
Health Research of Oklahoma, Oklahoma City
Arizona Arthritis & Rheumatology Associates, P. C., Phoenix
Arizona Arthritis & Rheumatology Associates, P. C., Mesa
Inland Rheumatology & Osteoporosis Medical Group, Upland
Desert Medical Advances, Palm Desert
Köhler & Milstein Research, Mérida
Medical Plus, Uherské Hradiště
PV Medical Services s.r.o., Zlín
RM Pharma Specialists S.A. de C.V., Mexico City
Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz
Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa Sól
Reumatika - Centrum Reumatologii, Warsaw
Nzoz Bif-Med, Bytom
Centro Reumatologico Caguas, Caguas
Royal Free Hospital, Barnet
Eli Lilly and Company
INDUSTRY